New COVID Variant “Cicada” Draws Attention as It Spreads Across Multiple Countries

A Newly Identified Variant Gains Focus

A new COVID variant is beginning to spread globally, prompting increased attention from scientists and health experts.

The strain, known as BA.3.2, has also been given the nickname “Cicada” due to its unusual pattern of emergence.

While still relatively limited in overall cases, its characteristics have led researchers to study it more closely.

Why It’s Called “Cicada”

The nickname comes from the insect known for remaining underground for long periods before suddenly appearing.

Similarly, this variant was first identified in South Africa in 2024 but remained largely unnoticed for some time.

It has now reappeared and begun spreading across multiple regions, drawing renewed interest.

Distinct Genetic Features Set It Apart

One of the main reasons BA.3.2 is attracting attention is its genetic makeup.

Experts have pointed to a large number of changes in the virus’s spike protein, which differentiates it from other circulating variants.

“Perhaps more concerning is the variant’s slew of genetic changes in its spike protein, which set it apart from other variants circulating,” said Andrew Pekosz, Ph.D., a virologist at the Johns Hopkins Bloomberg School of Public Health, in an interview with TODAY.

A Higher Number of Mutations

Scientists estimate that the variant carries approximately 70 to 75 mutations in its spike protein.

This level of change is higher than what is typically seen in many current variants.

These mutations may influence how the virus spreads and interacts with the immune system.

How Variants Naturally Evolve

The virus that causes COVID-19 continues to change over time as it spreads.

This process leads to the emergence of new variants, most of which differ only slightly from one another.

However, BA.3.2 stands out because of the extent of its genetic differences.

Global Spread Expands

The variant has now been detected in more than 20 countries around the world.

In the United States, it is circulating in at least 25 states.

This spread has contributed to growing awareness among health officials and researchers.

Regional Patterns of Infection

While BA.3.2 currently represents a small share of total COVID cases globally, its presence varies by region.

In some parts of Europe, it has already accounted for a larger proportion of infections.

These regional differences are being closely monitored.

Potential Impact on Transmission

The number of mutations in the spike protein may make the variant easier to spread.

Changes in this part of the virus can affect how it attaches to human cells and moves between individuals.

Researchers are continuing to study these characteristics to better understand its behavior.

Questions About Immune Evasion

Another area of interest is how the variant interacts with existing immunity.

The genetic changes may allow it to partially evade immune responses developed from previous infections or vaccination.

This possibility is one reason experts are paying closer attention.

Reassurance About Severe Illness

Despite concerns about transmission and mutations, there is encouraging information as well.

Experts believe that current COVID vaccines still provide protection against severe illness.

This suggests that even if the variant spreads, it may not lead to more serious outcomes for most people.

Monitoring the Situation

Health authorities are continuing to track the spread and characteristics of BA.3.2.

Ongoing observation helps determine whether the variant will become more widespread or remain limited.

At this stage, its future trajectory is not yet clear.

Too Early to Predict Dominance

Although the variant has shown signs of growth in certain areas, it is still too early to determine its long-term impact.

Whether it will become a dominant strain remains uncertain.

Researchers emphasize the importance of continued monitoring before drawing conclusions.

A Developing Situation

The emergence of BA.3.2 highlights the ongoing evolution of the virus.

Each new variant presents questions about transmission, immunity, and public health response.

As more data becomes available, a clearer understanding of its role will emerge.

Staying Informed as Research Continues

For now, the “Cicada” variant represents another development in the broader landscape of COVID-19.

Scientists and health experts continue to study its characteristics and track its spread.

Public awareness and reliable information remain key as the situation evolves.